IP Library › Granted Patent US 12,241,093
Granted Patent B2
US 12,241,093 · App. 18/333,393 · Granted Mar 4, 2025

Biocatalysts for the preparation of hydroxy substituted carbamates

Inventors: Fabien Louis Cabirol (Dusseldorf, DE); Haibin Chen (Beijing, CN); Anupam Gohel (Bekasi, ID); Steven J. Collier (Concord, MA); Derek J. Smith (Singapore, SG); Birgit Kosjek (Westfield, NJ); Jacob Janey (New York, NY)
Assignee: Codexis, Inc.
C12N9/0006C12P13/00C12P13/001C12P13/02C12P41/002C12Y101/01184C12N15/70Y02P20/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,241,093
App. No.
18/333,393
Filed
Jun 12, 2023
Granted
Mar 4, 2025
Kind
B2
Art Unit
1652
USPC
435/190
Abstract

The present disclosure relates to engineered ketoreductase polypeptides for the preparation of hydroxyl substituted carbamate compounds, and polynucleotides, vectors, host cells, and methods of making and using the ketoreductase polypeptides.

Claims (10)

1. An engineered ketoreductase polypeptide capable of converting substrate compound (2), tert-butyl(1-oxo-1-phenylhex-5-yn-2-yl)carbamate, to product compound (1), tert-butyl(1-hydroxy-1-phenylhex-5-yn-2-yl)carbamate,

wherein the ketoreductase polypeptide comprises an amino acid sequence having at least 80% sequence identity to SEQ ID NO:4 and comprising a substitution at position 150 and/or 198, further comprising one or more residue differences as compared to SEQ ID NO:4 selected from X17R; X40R; X64V; X71P; X94P; X144V; X147I; X157C; X196M; and X206F.

2. The engineered ketoreductase polypeptide of claim 1 , wherein the amino acid sequence of said ketoreductase polypeptide further comprises one or more residue differences as compared to SEQ ID NO:4 selected from: X7S; X23V; X27L; X29G; X60I; X87L; X95M; X105G; X113I; X122A; X127R; X131S; X145L; X152G; X153G; X173L; X196M; X208R; X216R; X221S; X243S; X245I; X249F; X249G; and X249Y.

3. The engineered ketoreductase polypeptide of claim 1 , wherein the amino acid sequence of said ketoreductase polypeptide comprises X17R; X40R; X64V; X71P; X94P; X144V; X147I; X150Y; X157C; X196M; X198S and X206F as compared to SEQ ID NO:4.

4. The engineered ketoreductase polypeptide of claim 1 , wherein the ketoreductase polypeptide is capable of converting the substrate compound (2) to the product compound (1) with at least 10 fold the activity of the reference polypeptide of SEQ ID NO:4, wherein the amino acid sequence further comprises one or more residue differences as compared to SEQ ID NO:4 selected from: X60I; X95M; X96L; X96Y; X127RX145I; X152G; X153G; X195A; X195G; X199H; X216R, X245I, X245F; X249Y; and X249F.

5. The engineered ketoreductase polypeptide of claim 1 , wherein the ketoreductase polypeptide has increased thermal stability as compared to the reference polypeptide of SEQ ID NO:4 or 32.

6. The engineered ketoreductase polypeptide of claim 1 , wherein the ketoreductase polypeptide is capable of forming product syn-tert-butyl(1-hydroxy-1-phenylhex-5-yn-2-yl)carbamate compounds (1a) and (1c)

in diastereomeric excess of anti-tert-butyl(1-hydroxy-1-phenylhex-5-yn-2-yl)carbamate compounds (1b) and (1d).

7. The engineered ketoreductase polypeptide of claim 6 , wherein the amino acid sequence of the ketoreductase polypeptide further comprises or more residue differences as compared to SEQ ID NO:4 selected from: X87L; X96L/Y; X195A/G; X199H; and X249F.

8. The engineered ketoreductase polypeptide of claim 7 , wherein said ketoreductase polypeptide is capable of forming product compounds (1a) and (1c) in a diastereomeric ratio of at least 50 over compounds (1b) and (1d).